Crescent Diagnostics is developing a new biomarker (BQT®) that uses fingernail structure to assess bone health.

The Bone Quality Test (BQT®) could be simpler, cheaper and more convenient than existing tests for osteoporosis and bone fracture risk. This novel test assesses bone microarchitecture rather than bone mineral density and can be carried out non-invasively at the point of care.

The consequences of osteoporosis, bone fracture can have important consequences for overall health and affects a significant proportion of the population around the world.

For further information please .